A new patient has been enrolled into InVivo Therapeutics’ INSPIRE Study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury) at Oregon Health & Science University (OHSU) in Portland, USA.
Jason J Chang, assistant professor of Neurological Surgery and co-study investigator, performed the surgery and implantation approximately 77 hours after the injury occurred.
Mark Perrin, InVivo’s chief executive officer and chairman, says, “We were pleased to hear that the procedure was a success and that the patient is doing well. We now have 15 patients enrolled and in follow up, and we look forward to completing enrolment in the INSPIRE study.”
